ICON to acquire PRA Health Sciences
Find out more
PRA Named Among America’s Best Large Companies
Find out more
Decentralized clinical trials: A better world is within reach—literally.
Find out more
The RACE Act is significantly changing pediatric clinical development. Are you ready?
Read More
Navigating COVID-19
Read More
We’re committed to reinventing research and making healthcare integrate seamlessly into real patients’ real lives. We provide the end-to-end drug development services to make it happen.
Explore what we can do for you
Ask the Experts Roundtable: Insights on Pfizer and Moderna’s Recent mRNA-Based Vaccine Developments
As the COVID-19 pandemic continues to challenge humankind worldwide, the medical industry and professionals alike are developing vaccines at…
HEALEY ALS Platform Trial Drives Innovation in ALS Clinical Research
Amyotrophic lateral sclerosis (ALS) is a lethal, relentlessly progressive neurodegenerative disease, and the most common adult-onset motor neuron…
PRA Health Sciences' 2nd Annual Celebration of World Children’s Day
Children and young adults across the globe are largely underrepresented in clinical research. While legal actions such as the Research to Accelerate…
What does the Future Hold for Stomach, Lung, and Testicular Cancer Treatments?
Cancer is a leading cause of death worldwide. Despite the lack of a definitive cure for cancer, there are many types of cancer treatments. A…
About PRA Health Sciences
We are a global healthcare intelligence partner, consistently ranked among the top CROs and best employers worldwide.
Executive Leadership
Since our inception in 1976, PRA has amassed a level of expertise that has enabled us to conduct complex global clinical trials across all…
Company History
Careers at PRA
We know that people are our greatest strength, so we work hard to hire the very best. Then we nurture, challenge, and reward them so they want to…
Medical Science Liaisons
PRA’s Medical Science Liaisons (MSLs) are highly skilled and trained scientific resources working for you throughout every step of product…
Integrated Drug Development
Pharmacovigilance & Patient Safety
We provide a comprehensive range of drug safety services, minimizing risk and protecting patient well-being from clinical development to…
Phase II-III
We support the phase II-III clinical development of niche treatments, blockbuster drugs, and biosimilars that help save lives.
Research Expertise
Clinical Research Associate
PRA Clinical Research Associates (CRAs) choose one of two career paths. They may work onsite with one of our top pharmaceutical clients. Or they may…
The Center for Vaccines and Emerging Infectious Diseases
We leverage our recruitment and retention expertise to accommodate rapid enrollment, as well as the right systems to make compliance easier,…
Real World Solutions
We combine real world evidence and real world research for real results. Product development is really complicated, but the reason we do it is…
Janssen Pharmaceuticals and PRA Health Sciences Launch First Fully Virtual Trial for Heart Failure Drug Approval
Janssen Pharmaceuticals and PRA Health Launch First Fully Virtual Trial for Heart Failure Drug Approval. Healthcare giant Janssen Pharmaceuticals and…
Healthcare Intelligence
Some people focus on their IQ—their intellectual and expertise-driven strategy. Others focus on their EQ—their ability to empathetically relate to…
Global Infrastructure
Rare Diseases Advisory Committee
Rare Diseases Advisory Committee—PRA is proud to join forces with a group of highly skilled and experienced patient advocates — collectively working…
The Center for Vaccines and Emerging Infectious Diseases
We leverage our recruitment and retention expertise to accommodate rapid enrollment, as well as the right systems to make compliance easier,…
The Center for Rare Diseases
We never forget that rare diseases alter entire lives—and we’re committed to changing that. Every day can be delayed, postponed, or canceled when…
The Center for Pediatric Clinical Development
We’re powering innovation in pediatric clinical trial design and implementation—because half isn’t whole. 70% of the medicines given to children have…
What’s your Healthcare Intelligence?
